| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5873853 | Journal of Stroke and Cerebrovascular Diseases | 2015 | 8 Pages |
Abstract
TCZ is a promising alternative for treating TA refractory to other biologics and for TA patients with stroke.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Mohammed PhD, MD, Derek MD, FRCPC, Elaine MD, FRCPC,